BC sells Pharmathen to Partners Group in EUR 1.6bn deal


BC Partners is to sell its stake in Pharmathen to Partners Group in a deal that values the generic contract development and manufacturing organisation (CDMO) at around EUR 1.6bn.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *